MedPath

PD-RX Pharmaceuticals, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

699

FDA:699

Drug Approvals

Gemfibrozil

Approval Date
Sep 16, 2025
FDA

Methocarbamol Tablets, USP, 500 mg

Approval Date
Sep 16, 2025
FDA

SIMVASTATIN

Approval Date
Sep 16, 2025
FDA

Levocetirizine Dihydrochloride

Approval Date
Sep 15, 2025
FDA

LAMOTRIGINE

Approval Date
Sep 15, 2025
FDA

Prednisone

Approval Date
Sep 15, 2025
FDA

Ondansetron Hydrochloride

Approval Date
Sep 15, 2025
FDA

Ondansetron

Approval Date
Sep 15, 2025
FDA

Ondansetron

Approval Date
Sep 15, 2025
FDA

Chlordiazepoxide Hydrochloride

Approval Date
Sep 15, 2025
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 70
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.